A Retrospective Review of Clinical Characteristics and Treatment Response in Body Dysmorphic Disorder Versus Obsessive-Compulsive Disorder
J Clin Psychiatry 2001;62:67-72
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Background: Although body dysmorphic disorder
(BDD) has many features in common with obsessive-compulsive
disorder (OCD) and is frequently comorbid with OCD, few studies
have directly compared the 2 disorders. Although BDD and OCD
respond to similar medications and cognitive-behavioral therapy
(CBT), their response to treatment has never been directly
Method: We studied 107 consecutive patients with
DSM-III-R OCD (N = 96) or BDD (N = 11) treated openly for 6 weeks
with intensive CBT, medication, and psychosocial rehabilitation,
in a specialized partial hospitalization program for severely ill
OCD patients. All patients were assessed, before and after
treatment, with the Yale-Brown Obsessive Compulsive Scale
(Y-BOCS), Hamilton Rating Scale for Depression (HAM-D), Hamilton
Rating Scale for Anxiety (HAM-A), and Global Assessment Scale
(GAS). Retrospectively, we compared the clinical characteristics,
symptom severity, and response to treatment of BDD patients with
those of OCD patients.
Results: BDD patients and OCD patients had
similar sex ratio, age, treatment duration, prevalence of
comorbid major depression, and pretreatment Y-BOCS and GAS
scores. BDD patients had significantly higher pretreatment HAM-D
and HAM-A scores. The proportions of patients treated with
serotonin reuptake inhibitors and antipsychotics did not differ
between groups. Both groups improved with treatment, with
significant (p < .001) changes in Y-BOCS, HAM-D, HAM-A, and
GAS scores. Change in Y-BOCS did not differ between groups, but
changes in HAM-D and HAM-A were significantly greater in BDD
patients than in OCD patients.
Conclusion: While BDD may be associated with
greater severity of depressive and anxiety symptoms than OCD,
this study suggests that BDD may respond to intensive, multimodal